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Abstract
Introduction: The human immunodeficiency virus 1 (HIV-1) pandemic is characterized by numerous distinct sub-epidemics
(clusters) that continually fuel local transmission. The aims of this study were to identify active growing clusters, to understand
which factors most influence the transmission dynamics, how these vary between different subtypes and how this information
might contribute to effective public health responses.
Methods: We used HIV-1 genomic sequence data linked to demographic factors that accounted for approximately 70% of all
new HIV-1 notifications in New South Wales (NSW). We assessed differences in transmission cluster dynamics between sub-
type B and circulating recombinant form 01_AE (CRF01_AE). Separate phylogenetic trees were estimated using 2919 subtype
B and 473 CRF01_AE sequences sampled between 2004 and 2018 in combination with global sequence data and NSW-speci-
fic clades were classified as clusters, pairs or singletons. Significant differences in demographics between subtypes were
assessed with Chi-Square statistics.
Results: We identified 104 subtype B and 11 CRF01_AE growing clusters containing a maximum of 29 and 11 sequences for
subtype B and CRF01_AE respectively. We observed a > 2-fold increase in the number of NSW-specific CRF01_AE clades
over time. Subtype B clusters were associated with individuals reporting men who have sex with men (MSM) as their transmis-
sion risk factor, being born in Australia, and being diagnosed during the early stage of infection (p < 0.01). CRF01_AE infec-
tions clusters were associated with infections among individuals diagnosed during the early stage of infection (p < 0.05) and
CRF01_AE singletons were more likely to be from infections among individuals reporting heterosexual transmission (p < 0.05).
We found six subtype B clusters with an above-average growth rate (>1.5 sequences / 6-months) and which consisted of a
majority of infections among MSM. We also found four active growing CRF01_AE clusters containing only infections among
MSM. Finally, we found 47 subtype B and seven CRF01_AE clusters that contained a large gap in time (>1 year) between
infections and may be indicative of intermediate transmissions via undiagnosed individuals.
Conclusions: The large number of active and growing clusters among MSM are the driving force of the ongoing epidemic in
NSW for subtype B and CRF01_AE.
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1 | INTRODUCTION
Australia is at the forefront of successful control of human
immunodeficiency virus type 1 (HIV-1) transmission due to
rapid and comprehensive public health responses from the
beginning of the epidemic in the 1980s. Australia has recently
experienced its first major decline in new HIV-1 infections in
ten years that is attributed to the successful rapid rollout of
pre-exposure prophylaxis (PrEP) among men who have sex
with men (MSM) [1,2]. New South Wales (NSW) the most
populated state in Australia, accounts for approximately one-
third of all HIV-1 notifications in the country; of the 963 new
HIV-1 notifications reported in 2017 in Australia, 349 were
from NSW [1,3]. NSW met the UNAIDS 90-90-90 targets in
2016 [4] and the number of new HIV-1 notification decreased
by 13% from 318 in 2016 to 277 in 2018. However, a slight
increase in new HIV-1 notification was reported for 2019
(n = 282) [3]. Thus, current enhanced prevention strategies
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alone are not sufficient to virtually eliminate HIV-1 transmis-
sion.
HIV-1 transmission is often characterized by the presence
of numerous transmission clusters that are likely to play a key
role in sustaining the epidemic and thus should be prioritized
for HIV prevention [5,6]. Phylogenetic analysis provides a
powerful tool to investigate HIV-1 transmission dynamics and
has been used to determine epidemiological parameters, such
as the transmission rate (i.e. basic reproductive number, R0)
[7] and to what extent HIV-1 transmission clusters are self-
sustained [5]. Molecular phylogeny can identify transmission
clusters that would otherwise be missed by patient demo-
graphic data alone [8], particularly for new HIV-1 notifications
that are made during the chronic or advanced stages of infec-
tion [9,10]. The fine detail of transmission dynamics of HIV-1
in Australia is not well understood, as current surveillance
reports rely on basic demographic data alone and do not
include molecular epidemiological data [1]. Specifically, it is not
known if the subtype B epidemic is characterized by many
small transmission clusters, as often observed in other coun-
tries [11], or fewer but larger sub-epidemics that are more
common in regions with less population migration [12]. In
addition, it remains unclear to what extent demographic fac-
tors such as transmission risk factor or stage of infection at
diagnosis differ between clusters and subtypes. These are key
factors that, if known, could improve Australia’s public health
response [13].
The aim of this study was to understand changes in cluster
dynamics over time in NSW. We performed phylogenetic anal-
yses to identify sequence clusters that represent sub-epi-
demics in the two most common HIV-1 subtypes B and
CRF01_AE [14] and followed the transmission dynamics in
these clusters across a five-year time period.
2 | METHODS
2.1 | Ethics
Ethical approval was obtained by the NSW Population and
Health Services Research Ethics Committee and the ACON
Research Ethics Review Committee (RERC) [AU RED Refer-
ence: HREC/15/CIHS/38, Cancer Institute NSW reference
number: 2015/08/605]. The HIV/AIDS Legal Centre was con-
sulted for legal advice on data anonymity. Both, sequence and
demographic data are routinely collected and are irreversibly
de-identified for public health surveillance. A waiver for con-
sent of the individual to use their health information was
granted by the Ethics Committee.
2.2 | Sequence data and phylogeny
The NSW HIV-1 database contains all protease, reverse tran-
scriptase and integrase sequences sampled in NSW between
2004 and 2018. The HIV-1 subtype for these sequences was
determined using the Stanford HIV subtyping tool [15,16] and
confirmed by phylogeny, as described previously [14]. Only
the first available sequence for each individual covering the
protease and reverse transcriptase and that were classified as
subtype B and CRF01_AE were included in the analysis. The
final NSW data set consisted of 2919 subtype B and 473
CRF01_AE sequences. Global sequences (n = 13 194 subtype
B; n = 4091 CRF01_AE) were selected via BLASTN search to
identify those global sequences that are most similar to the
sequences used in this study, and thus, represent background
data to the NSW data [5,17,18]. A subtype C sequence (ac-
cession number AY162223) and a subtype B sequence (acces-
sion number NC_001802) was added as an outgroup to the
subtype B and CRF01_AE data set respectively. Sequences
were aligned in MAFFT [19] implementing the L-INS-I algo-
rithm. Alignments were visually inspected in Geneious 11.1.3
(https://www.geneious.com) and codons associated with drug
resistance mutations were removed (according to reference
sequence HXB2; accession number K03455.1) [20]. Phyloge-
netic trees were estimated using FastTreeMP v2.1.10 [21]
(Figure S1).
2.3 | Data subsets
A baseline data set was established using NSW sequences
from 2004 to 2012 plus global sequences derived from
the Los Alamos National Lab (LANL) database (http://www.
hiv.lanl.gov/). This global sequence data set was used as
background to identify and separate out local transmission
clusters within NSW. Only clusters not including global
sequences were counted as true local clusters (see below).
This approach has been widely established as a robust
alternative to other cluster identification methods [5,17]. In
brief, each HIV-1 sequence from NSW used in this study
was compared against the LANL database via BLASTN and
the 50 best matches were extracted. Thus the baseline
data set contains NSW sequences from infections sampled
between 2004 and 2012 plus global sequences (no time
constraints for the latter). This baseline data set represents
the basis for cluster growth estimates. The 2013 cut-off
was used as it represents the first full year after a new
five-year NSW HIV Strategy was released. This strategy
outlines changes in public health approaches to HIV pre-
vention for the years 2012 to 2016 [22]. NSW sequences
sampled from 2013 were added to the baseline data set
in six-month intervals forming 12 data subsets for subtype
B and 12 data subsets for CRF01_AE (Figure S1).
Sequence phylogeny was estimated separately for each of
the 12 subtype B and 12 CRF01_AE data subsets.
Sequence phylogeny for the complete data set, that is glo-
bal data plus NSW sequences 2004 to 2018 are shown in
Figure S2.
2.4 | Characterization of NSW-specific clusters
An internal R script was used to extract clades within the phy-
logeny that only contained sequences from NSW, that is were
monophyletic [14,17]. NSW-specific sequences that fell into
neither category were defined as singletons (Figure S1). Clus-
ters and pairs identified at baseline were followed across time
between 2013 and 2018. If a sequence from a new data sub-
set fell into one of these clades they were classified as “grow-
ing.” Thus, clusters were then separated into those that grew
in size over time and those that did not (Figure S1). Some
clusters displayed phylogenetic instability through time, that is
their topology in the trees was unstable due to poor node
support, and thus were not included in the analysis of cluster
growth.
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2.5 | Demographic factors
Metadata derived from the notifications database included: (i)
sex: male, female; (ii) self-reported region of acquisition: Aus-
tralia, not Australia; (iii) region of birth: Australian, non-Aus-
tralian, and the latter further subdivided into Asian, European
and other; (iv) transmission risk factor: MSM (men who have
sex with men), heterosexual, PWID (people who inject drugs),
other and (v) stage of infection at diagnosis. Infection stage
categories were adapted from the NSW Ministry of Health
definitions [23]: early = evidence of an HIV-1 infection
acquired within 12 months of diagnosis or CD4 T-cell
count > 500 cells/mm3, CD4 < 500 (cell count 350 to
499 cells/mm3), CD4 < 350 (cell count 200 to 349 cells/mm3)
and advanced = CD4 count <200 cells/mm3 or AIDS defining
illness in absence of early diagnosis. Time intervals from infec-
tion to CD4 T-cell counts at diagnosis were derived from the
results of the CASCADE study [24]: early = <1 year,
CD4 < 500 = 1 year, CD4 < 350 = 4 years, and
CD4 < 200 = 8 years. Chi-square tests of independence were
performed in R (version 3.6.2) using the gplots and corrplots
packages [25-27].
3 | RESULTS
3.1 | Subtype-specific differences in cluster
dynamics over time
The sequences with linked demographics used in this study
cover approximately 70% of newly notified infections and rep-
resent even greater proportions for recent years (87% and
89% for 2017 and 2018 respectively). The number of
sequences from new notifications used in the data subsets did
not increase over time for subtype B (p = 0.957) but did for
CRF01_AE (p < 0.01), increasing from 14 sequences in June
2013 to 31 in December 2018 (Figure 1). Nevertheless, the
cumulative number of subtype B pairs increased slightly over
time from 176 to 192 between June 2013 and December
2018 (p < 0.05), and the number of B clusters increased sub-
stantially from 169 in the interval ending June 2013 to 242
clusters in the interval ending December 2018 (p < 0.001).
For every six months interval, more B clusters than sequence
pairs were found, except for the first six months of 2013
when there were 176 subtype B sequence pairs and 169 clus-
ters. Also, sequence pairs represented 51% of all NSW-speci-
fic subtype B nodes in the interval to June 2013 and 44% in
the interval ending December 2018. The opposite was
observed for CRF01_AE. More sequence pairs were identified
than clusters for each interval from June 2014 to December
2018 (Figure 1). Within the time period June 2013 to Decem-
ber 2018, 14 sequence pairs and 14 clusters were identified.
Both, the number of CRF01_AE pairs and clusters increased
by >2-fold in these five years (p < 0.001) from 14 to 36 and
14 to 29 respectively (Figure 1). Overall, the majority of sub-
type B infections were associated with a clade. The lowest
proportion of subtype B singletons (33%) was identified in the
interval to December 2016, whereas the highest (55%) was in
the interval to December 2017 (Figure 1B). In stark contrast,
the majority of CRF01_AE infections were singletons (average
65%). The highest proportion of CRF01_AE singletons was
observed in the interval ending June 2017 (87%) and the
lowest proportion was observed in the interval ending Decem-
ber 2015 (54%). No difference in the proportion of singletons
was found over time in either subtype.
3.2 | Subtype-specific differences in demographics
associated with sequence clusters
There were strong associations between demographic factors
such as region acquired, region of birth, transmission risk fac-
tor, and stage of infection at diagnosis and subtype. Sex was
not included in the statistical analysis due to a lack of demo-
graphic variation (Table 1). Infections acquired in Australia
were positively associated with being of subtype B origin,
whereas infections acquired elsewhere were associated with
being CRF01_AE (p < 0.001, Figure 2A). Similarly, infections in
individuals born in Australia were associated with being sub-
type B and infections in individuals not born in Australia were
more likely to be CRF01_AE (p < 0.001). More specifically,
infections among Asian-born individuals were associated with
being CRF01_AE, whereas infections among European-born
individuals were associated with being subtype B (p < 0.001).
For both subtypes, the majority of infections were acquired
via MSM transmission (86% subtype B, 64% CRF01_AE).
However, significantly more CRF01_AE infections were
acquired via heterosexual transmission (29%) compared to
subtype B (8%, <0.001). In addition, CRF01_AE was more
likely associated with HIV notifications identified during the
advanced stage of infection (29% of CRF01_AE), compared to
19% of subtype B infections being from individuals in the
advanced stage of infection (p < 0.001).
Overall, 44% and 9% of subtype B, and 19% and 15% of
CRF01_AE infections were associated with clusters and pairs
respectively (Table 1). Infections acquired in Australia were
associated with being in clusters for both subtype B and
CRF01_AE, whereas infections not acquired in Australia were
associated with being singletons for both subtypes
(p < 0.001). This latter association was stronger for subtype B
than CRF01_AE (Figure 2B). For subtype B, there was a posi-
tive association for infections in non-Australian born individu-
als (38%), and for infections diagnosed at the advanced stage
of infection (24%) with being singletons (Figure 2; p < 0.001).
No difference was found for infections in non-Australian-born
individuals from different regions between being either in
clusters or not (p = 0.108). In contrast, infections in Aus-
tralian-born, and individuals in their early stage of infection
had a positive association with being part of a cluster (27%
and 64% respectively; p < 0.001). No associations were found
for any of the transmission risk factors and being in a cluster
or pair, or being a singleton (p = 0.106).
The proportion of infections among Australian-born and
non-Australian born individuals were not significantly different
in CRF01_AE clusters, pairs, or being singletons (p = 0.511,
Figure 2B). However, infections in Asian-born individuals were
associated with being singletons, but infections in individuals
born in other regions were associated with clusters
(p < 0.05). Infections in individuals diagnosed during the early
stage of infection showed a strong positive correlation with
being in a cluster, representing 57% of all infections associ-
ated with clusters (p = 0.05). Also, more CRF01_AE infections
in individuals diagnosed at an advanced stage of infection
were classified as singletons (33%) than in clusters (21%).
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There was a negative association for infections associated
with heterosexual transmission and belonging to a cluster
(p = 0.05), with 14% of sequences in clusters derived from
infections acquired via heterosexual transmission and this risk
factor contributed to 31% and 32% for pairs and singletons
respectively (Table 1).
3.3 | Large delay in notifications of new infections
Fifty-two subtype B and seven CRF01_AE clusters were iden-
tified in the June 13 data subset that did not grow in size in
the subsequent five years. These “non-growing” clusters were
regarded as potentially extinct. In contrast, 104 subtype B
and 11 CRF01_AE clusters grew in size (Figure 3A). Between
2013 and 2018, 43% of growing subtype B clusters increased
by only one infection, 39% by two, three or four, and 20% by
five or more infections. Overall, the largest increase in cluster
size was from seven in 2013 to 29 infections in 2018 which
was also the largest subtype B cluster identified. The largest
increase in cluster size was also seen in the biggest
CRF01_AE cluster growing from three in 2013 to nine infec-
tions in 2018. A second cluster grew by five and four (36% of
growing CRF01_AE clusters) grew by only one and five (45%)
by two or three infections from 2013 to 2018. Also, 39 sub-
type B clusters (38% of growing B clusters) started as
sequence pairs, developing into clusters with up to nine infec-
tions by 2018. For CRF01_AE, seven out of the 11 growing
clusters (63%) started as pairs with one growing to seven
sequences by December 2018.
The cluster growth rate did not differ between the two sub-
types. The median rate for cluster growth was 0.33 and 0.4
infections per six-month interval for subtype B and CRF01_AE
respectively (Figure 3A). Two CRF01_AE clusters grew at a
rate of 1 infection per six months, seven clusters grew from a
pair to a cluster with up to seven infections. The largest
CRF01_AE cluster showed an average growth rate of 0.55
infections per six-month interval. In contrast, six subtype B
clusters grew at a rate of >1.5 infections per six-month inter-
val, including the largest cluster which consisted of an









































































Figure 1. Number of clusters for subtype B and CRF01_AE between 2013 and 2018. Top Panel The total number of sequences (light grey)
and new sequences added (dark grey) accumulating over time. Middle Panel: The total number of pairs (yellow) and clusters (light blue) identified
across all data subsets. Note the different y-axis scales for subtype B and CRF01_AE. Lower Panel: Proportion of sequences from newly notified
infections belonging to a cluster (light blue), a sequence pair (yellow), or being a singleton (green) across the different data subsets. D, interval
ending in December; J, interval ending in June.
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Seventy-eight clusters grew from being a pair to a cluster
with up to nine infections.
Notably, numerous clusters did not grow continuously over
time but rather one or two infections were added after pro-
longed time intervals. For example, one subtype B cluster con-
sisting of 14 infections contained 13 in June 2013 and one in
2018. One CRF01_AE cluster contained three infections in
December 2013 and expanded to four by June 2016 and five
by June 2018 (Figure 3B). In this cohort, it was not uncommon
for HIV-1 infections to be diagnosed one year or more after
transmission, as reflected by the stage of infection at diagnosis;
44% of subtype B and 60% of CRF01_AE infections were in
individuals in the non-early stages of their infection (Table 1).
Within subtype B clusters, 50 sequences were obtained from
individuals during the non-early infectious stages that had a
sampling time gap of >1 year to the next most recent sequence
in the same cluster. In addition, we identified late additions in
47 clusters (45% of the 104 growing clusters) that were linked
to other infections from individuals in their early stage of infec-
tion. Also, 42% of the 45 clusters (n = 19) contained a time gap
of 2.5 to 4.5 years and 16% of clusters (n = 7) contained a time
gap of five to six years despite infections being derived individu-
als in the early stage of infection. For CRF01_AE the largest
time interval between sampling in the 11 growing clusters was
three years. This was found in two clusters (18%). In both
instances, the infections were among individuals in their non-
early stages of infection. In contrast, 36% of growing CRF01_AE
clusters (n = 4) contained a time gap of 1.5 to 2.5 years that
was associated with infections among individuals during their
early stage of infection.
3.4 | Infections from the early stage are
significantly associated with growing clusters
Demographic differences were investigated within potentially
extinct clusters and growing clusters for both subtypes
Table 1. Summary of demographic factors for subtype B and CRF01_AE infections
Subtype B CRF01_AE
All (n = 1666)
Clusters
(n = 733, 44%)
Pairs
(n = 146, 9%)
Singletons




(n = 76, 19%)
Pairs
(n = 62, 15%)
Singletons
(n = 268, 66%)
Sex
Male 0.82 (1378) 0.83 (609) 0.84 (122) 0.81 (636) 0.72 (293) 0.86 (65) 0.274 (46) 0.68 (182)
Female 0.02 (37) 0.02 (16) 0.02 (4) 0.02 (17) 0.09 (37) 0.07 (5) 0.11 (7) 0.09 (25)
No data 0.82 (1378) 0.83 (609) 0.84 (122) 0.81 (636) 0.72 (293) 0.86 (65) 0.274 (46) 0.68 (182)
Region acquired
Australia 0.60 (1002) 0.72 (525) 0.66 (96) 0.48 (381) 0.31 (125) 0.66 (50) 0.37 (23) 0.19 (52)
Not
Australia
0.15 (243) 0.06 (41) 0.16 (23) 0.23 (179) 0.55 (222) 0.24 (18) 0.40 (25) 0.67 (179)
No data 0.25 (421) 0.23 (167) 0.18 (27) 0.29 (227) 0.14 (59) 0.11 (8) 0.23 (14) 0.14 (37)
Region born
Australian 0.62 (1038) 0.68 (495) 0.58 (85) 0.57 (449) 0.33 (134) 0.38 (29) 0.34 (21) 0.31 (84)
Non-
Australian
0.33 (561) 0.27 (201) 0.140 (58) 0.38 (298) 0.65 (264) 0.61 (46) 0.61 (38) 0.68 (180)
Asia 0.11 (188) 0.09 (65) 0.09 (13) 0.14 (110) 0.53 (216) 0.43 (33) 0.45 (28) 0.58 (155)
Europe 0.09 (156) 0.08 (62) 0.15 (22) 0.09 (72) — — — —
Other 0.12 (213) 0.10 (74) 0.16 (23) 0.15 (116) 0.12 (48)* 0.17 (13)* 0.16 (10)* 0.09 (25)*
No data 0.05 (81) 0.05 (37) 0.02 (3) 0.05 (40) 0.02 (8) 0.01 (1) 0.05 (3) 0.01 (4)
Transmission risk factor
MSM 0.86 (1445) 0.88 (642) 0.86 (125) 0.85 (667) 0.64 (260) 0.74 (56) 0.61 (38) 0.62 (166)
Heterosexual 0.08 (138) 0.06 (45) 0.10 (14) 0.10 (77) 0.29 (116) 0.14 (11) 0.31 (19) 0.32 (86)
PWID/Other 0.06 (97) 0.06 (46) 0.05 (7) 0.05 (43) 0.07 (30) 0.12 (9) 0.08 (5) 0.06 (16)
Stage of infection at diagnosis
Early 0.56 (943) 0.64 (467) 0.53 (77) 0.50 (392) 0.40 (162) 0.57 (43) 0.42 (26) 0.35 (93)
CD4 < 500 0.11 (183) 0.10 (75) 0.13 (19) 0.11 (88) 0.15 (61) 0.11 (8) 0.15 (9) 0.16 (44)
CD4 < 350 0.11 (177) 0.09 (67) 0.14 (20) 0.11 (90) 0.13 (53) 0.09 (7) 0.19 (12) 0.13 (34)
Advanced 0.19 (319) 0.14 (103) 0.18 (27) 0.24 (185) 0.29 (117) 0.21 (16) 0.21 (13) 0.33 (88)
No data 0.03 (58) 0.03 (21) 0.02 (3) 0.04 (32) 0.03 (13) 0.03 (2) 0.03 (2) 0.03 (9)
As there were less than five sequences with the PWID transmission risk factor, this risk factor category was combined with “Other”. In the cate-
gory “Region born" non-Australian is further subdivided into born in Asia, Europe and others for subtype B, and born in Asia and others for
CRF01_AE. MSM, men who have sex with men; PWID, person who inject drugs.
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(Table S1). For this analysis, 11 subtype B and two CRF01_AE
clusters which appeared to be growing in the time period 2013
to 2018 but which contained exclusively infections among indi-
viduals in their advanced stage infection were redefined as
potentially extinct (Figure 3B). This resulted in 93 growing clus-
ters and 11 potentially extinct clusters for subtype B, and nine
growing and nine potentially extinct clusters for CRF01_AE. A
significant positive correlation was found for subtype B infec-
tions from the advanced stage being associated with potentially
extinct clusters (p < 0.05, Figure S3), however, this might be
biased due to the definition of clusters containing sequences
sampled after 2013 from individuals during advanced infections
being potentially extinct. Interestingly, no difference was found
for infections among Australian-born and non-Australian-born
individuals being more likely associated with growing clusters
for either subtype. However, subtype B infections among indi-
viduals born in “other” region were more likely to be found in
extinct clusters (p < 0.05). In contrast, CRF01_AE infections
reported to have been acquired outside Australia were associ-
ated with extinct clusters (p < 0.05), as well as infections
acquired via non-MSM transmission (p < 0.01).
4 | DISCUSSION
We used annotated HIV-1 genomic sequence data and per-
formed a phylogenetic analysis to describe cluster growth
over time in NSW, Australia, and how transmission dynamics
are influenced more by individuals’ demographics than virus































































































































































































































p <0.001*** p <0.001*** p = 0.108 p = 0.106 p <0.001***
p <0.001*** p = 0.511 p <0.05* p <0.05* p <0.05*
(a)
(b)
Figure 2. Correlations between sequence demographics and cluster association. Correlation plots shows the Chi-square statistics for demo-
graphics. For each association (cell) the Pearson residual value is shown. A positive association is indicated in blue, a negative association is shown
in red. More intense colours and larger squares equal stronger contribution to the overall Chi-square score, and which are indicated below each
correlation plot. As there were less than five sequences with the PWID transmission risk factor, this risk factor category was combined with
“Other”. (A) Demographics compared to all subtype B and CRF01_AE, (B) Demographics compared to infections associated with clusters, pairs
and singletons for subtype B (top panel) and CRF01_AE (bottom panel). MSM, men who have sex with men; PWID, person who inject drugs.
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are more likely to have been acquired in Australia, as they are
among individuals born in Australia, and those who were diag-
nosed at the early stage of their infection, regardless of the
viral subtype. We also show that for both subtypes B and
CRF01_AE, infections acquired outside Australia and among
Asian-born individuals are more likely to be singletons, and
thus did not lead to ongoing local transmission.
Overall, demographics differed substantially between sub-
type B and CRF01_AE infections. This is an expected result
due to their evolutionary history in Australia. Subtype B has
always been the dominant subtype and its transmission has
been endemic for over 30 years since the beginning of the
HIV-1 pandemic in the 1980s [1]. Thus, it is not surprising
that we found that the majority of subtype B infections that
were reported to have been acquired within Australia were in
Australian-born individuals, and were characterized by numer-
ous local transmission clusters, all of which is expected for an
established endemic disease.
In contrast, CRF01_AE, similar to other non-B subtypes, is
historically associated with heterosexual contact and acquisi-
tion outside Australia [28]. In our study, CRF01_AE was char-
acterized by numerous sequence pairs and a majority of
infections being singletons, which is more indicative of multiple
introductions with only limited ongoing transmission [14]. This
finding was supported by the associated demographic data,
with a majority of these infections reported to be acquired
outside Australia, and among individuals born in Asia. Also, we
found a negative association with CRF01_AE infections in indi-
viduals reporting heterosexual transmission and being in clus-
ters. Of the 22 CRF01_AE clusters seven (32%) contained
exclusively infections among individuals reporting a transmis-
sion risk other than MSM, with the largest of these clusters
only containing four infections. Our finding is similar to that of
a recent study from the state of Victoria, Australia, which
found that heterosexual transmissions rarely lead to more












































































Figure 3. Time intervals between sampling of infections in growing clusters. (A) (left and middle panels) Changes in cluster size shown as the
difference between the minimum number of sequences when the cluster was first identified in the phylogeny to the maximum number of
sequences when the most recent sequence associated with that cluster was sampled. (right panel) Cluster growth rate was normalised to the
number of sequences added per 6-months interval. (B) Cluster size at baseline (including sequence data from 2004 to 2012). (middle) Each line
represents a cluster and the circles represent a sequence sampled during that data subset coloured according to the stage of infection at diagno-
sis. Blue = early, green = CD4 T-cell count < 500, light blue CD4 < 350, red = advanced (see Material and Methods), white = no data. Grey cir-
cles represent the starting point of clusters that appeared between 2013 and 2018. Red lines indicated clusters that only contained sequences
sampled during the advanced stage of infection for sampling dates 2013 - 2018 and thus are regarded as potentially extinct. (right) Final cluster
size at the end of the time period investigated. Top panels show data for subtype B, bottom panels show data for CRF01_AE. D, December; J,
June.
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found nine active growing clusters for CRF01_AE, of which
seven contained infections from notifications in 2018. Thus,
these active transmission clusters should be monitored to
ensure contact tracing was successful in stopping further
transmission. One of these clusters contained only infections
among individuals reporting heterosexual transmission, and
what could be evidence for one single active growing hetero-
sexual transmission cluster in NSW. The remaining six clusters
consisted mainly of infections among individuals reporting
MSM transmission and we found here that MSM transmission
was positively associated with growing clusters (p < 0.01) for
CRF01_AE infections. An older study from Victoria also
reported that MSM transmission was be the main risk factor
for transmission clusters. That study also found an increase in
MSM transmission for non-B subtype infections [30].
This dominance of MSM transmission was more evident for
subtype B infections. Of the 157 B clusters found here, 87
(55%) contained exclusively infections among individuals
reporting MSM transmission with a maximum of 17
sequences. Five of these MSM-only clusters also had a faster
than average growth rate (>1.5 sequences per 6-months). The
identification of such fast-growing clusters is crucial for epi-
demic control and should be prioritized for public health inter-
ventions [31]. Only two subtype B clusters were found that
did not contain any infections attributed to MSM transmission,
but both of these were classified as extinct.
We show here a strong positive association for infections
from early stage being in clusters for both subtypes. Thus, a
large proportion of HIV-1 transmission occurs shortly after
HIV-1 acquisition. This short window is characterized by an
asymptomatic phase and usually higher viraemia that facili-
tates transmission [32]. Notably, timely HIV-1 diagnoses and
immediate access to therapy has been successfully advocated
in NSW for prevention of HIV-1 transmission [33]. A NSW
study that analysed the performance of a rapid HIV test
among men found that among 94 MSM diagnosed in 2013 to
2014, 39% were diagnosed within three months of infection
[34]. NSW data reporting on follow-up at six months after
diagnosis show that among people diagnosed between Jan-
uary and June 2019 the median time to treatment was only
16 days after diagnosis [3]. Nevertheless, we observed here
both the presence “late diagnoses,” that is sequences sampled
during the advanced stage of infection being linked to clusters,
and “late additions,” that is sequences sampled during the
early stage of infection but >1 year after the previous most
closely related sequence.
We identified 11 subtype B and two CRF01_AE clusters
that by molecular data alone were seemingly growing between
2013 and 2018, but these additional sequences were from
infections that likely occurred over seven years prior suggest-
ing these clusters are in fact extinct. Importantly, notifications
from people who are diagnosed with HIV-1 more than one
year after a transmission event pose challenges for timely
monitoring of cluster growth, as these infections occurred
some time prior to diagnosis. Such late diagnoses are further
problematic for public health interventions as this delays
access to treatment, and control measures such as contact
tracing are less likely to be effective, as contact tracing is
most successful when conducted soon after a transmission
event [35]. In addition, we identified 47 clusters that con-
tained a total of 116 infections exclusively among individuals
in their early stage of infection but had a large time gap
(>1 year) to the most recent previous sequence in the same
cluster. Thirteen percent of these sequences had a time gap
of >4 years. Such a delay in HIV-1 notifications could have dif-
ferent reasons, most probable being missing data. First, it is
probable that these sequences represent notifications from
new infections passed on from undiagnosed individuals. We
know that approximately 11% of people living with HIV-1 liv-
ing in Australia are undiagnosed and these undiagnosed infec-
tions are one of the major contributors of new infections [36].
Second, we miss sequences from inter-state transmission that
could “fill-in” the time gaps observed. A study by Castley et al.
reported the presence of inter-state transmission with approx-
imately 40% of identified clusters containing at least two
infections from different states [37]. Sequence data from that
study were included here but lacked associated demographic
data and only included sequences up to 2012, thus, it did not
cover our period of cluster growth analysis. Finally, we cannot
exclude significant uncertainties for the estimates of time
since seroconversion, which could also explain some of the
large time gaps observed. Using CD4 data alone might not be
sufficient to estimate time point of infection. Studies of rates
of CD4 decline have shown that various factors can influence
the speed of decline. For example co-infection with HCV can
increase the rate of decline of CD4 cells, [38] and CD4 counts
may vary between different geographic areas with faster CD4
decline observed in Asia compared to Europe [39].
Our study has some limitations: First, our cluster analysis
was rather conservative by implementing a 100% NSW-speci-
fic node cut off and only comparing “phylogenetically” stable
clusters, whereas other studies have used a cut-off of 80%
[5]. However, we believe that a cut off of 100% is more suit-
able and precise for the robust identification of sequence
pairs and small clusters (<10 sequences). Second, the data set
used lacks sequence data from other Australian states, thus,
we may have missed potential transmissions from interstate.
Also, we show here that for both subtypes B and CRF01_AE,
only infections among individuals diagnosed during the early
stage of infection were associated with clusters, whereas
infections among individuals diagnosed during the advanced
stage of infection were associated with being singletons. How-
ever, this could be due to a bias in the data as contact tracing
and hence “linked infections” is more successful in the first
months after transmission, that is during early stages of infec-
tion. Also infections notified early are more likely to have been
acquired locally via local transmission and having a greater
potential for matching in the data set. Thus, we might be sim-
ply missing sequences linking to infections from advanced
stages in our data. Finally, we lack demographic data regarding
the ethnicity and travel history of people living with HIV,
which could have helped assess the impact of migration and
travel on HIV infection rates and transmission.
5 | CONCLUSIONS
We report on subtype-specific transmission dynamics with
subtype B being dominated by larger clusters and CRF01_AE
by sequence pairs. Infections among these two subtypes also
differ in their associations with different demographic factors,
particularly the transmission risk factor and stage of infection
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at diagnosis. Importantly, for both subtypes, we identified
numerous active clusters that could be the focus of increased
monitoring by public health to avoid an expansion of new
HIV-1 infections within the state. We show here the impor-
tance of utilizing molecular data for prevention of transmission
and to inform the HIV-1 public health response.
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Figure S1. Data selection. A flow chart describing the proce-
dure for the sequence selection for subtype B (left) and
CRF01_AE (right). Sequences were extracted from the NSW
HIV database and split according to time point sampled form-
ing 12 data subsets for each subtype. Global sequences were
then added to each of the data subsets and a phylogenetic
tree was estimated for each. Clusters were defined as nodes
containing only NSW sequences (light blue) within the global
phylogeny (none NSW sequences are shown in grey).
Sequences pairs were defined as nodes containing two NSW
sequences (yellow), all other NSW sequences were defined to
be singletons (green). Example of cluster growth over time.
Branches in light blue represent a cluster with six sequences
identified in data subset Dec 2015, and which grew by two
sequences in the subsequent data subset. Branch lengths rep-
resents nucleotide substitutions per site.
Figure S2. Phylogeny. Maximum likelihood trees harbouring all
sequence data used in this study, i.e. data subset Dec 18, are
shown for subtype B (left) and CRF01_AE (right). Grey global
sequences, black singleton sequences, yellow, sequence pairs,
and light blue clusters. Branch lengths indicates nucleotide
substitutions per site.
Figure S3. Correlations between sequence demographics and
cluster association for subtype B. Plots shows correlations for
each cell (demographic vs growing cluster, potentially extinct
cluster, sequence pair). As there were less than five sequences
with the PWID transmission risk factor, this risk factor cate-
gory was combined with “Other”. Positive values (blue) depict
a positive association, negative values (red) depict a negative
association. The bigger the square, the stronger the associa-
tion. Region acquired contained a large proportion of missing
data points (Table S1), which were excluded here. P values
represent the overall statistic for the corresponding category.
MSM, men who have sex with men, Heterosexual; PWID, per-
son who inject drugs.
Table S1. Demographic factors for sequences associated with
growing clusters, potentially extinct clusters, or pairs
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